John Fry Email and Phone Number
John Fry work email
- Valid
- Valid
- Valid
John Fry personal email
John Fry phone numbers
🔲 Program Team Leader Highly accomplished and successful oncology therapeutic asset leader with comprehensive drug development and global commercialization experience spearheading high-profile global oncology asset development programs. Results-driven asset leader with over 14 years’ experience leading early to late-stage cross-functional drug development teams with a heightened emphasis on ensuring successful global commercialization. Skilled at effective cross-functional leadership, collaboration, communication and organizational influence in both large and small companies. Solid track record of recognized accomplishments with progressive roles of increasing responsibility. Primary point of contact for Executive Leadership with a solid track record of success leading assets and functions in complex matrix environments.🔲 Areas of Expertise◾️Drug Development & Commercialization ◾️ Cross-Functional Team Leadership & Coaching ◾️ Drug Development Operations ◾️ Partnerships & Alliances ◾️ NDA and BLA Submissions ◾️ Biomarker Development ◾️ Lifecycle / Portfolio Strategy ◾️ Asset Valuations ◾️ TPP Development ◾️ Competitive Intelligence ◾️ Global Launches ◾️ Alliance Management ◾️ Executive Communications
Pepromene Bio
View-
Executive Director Of Business Development And Alliance ManagementPepromene Bio Jun 2024 - PresentIrvine, California, United States
-
Principal ConsultantJrf Oncology, Biopharma Consulting Llc Oct 2023 - May 2024Los Angeles County, California, United StatesAccomplished oncology drug development and commercialization executive with experience spearheading high-profile global oncology asset development and commercialization programs in both small and large biotech organizations. Solid track record of success leading assets and functional teams in complex matrix environments.Core competencies include:Program leadership & managementTPP development and testingClinical development strategyCross functional asset leadershipCDx partner selection NDA/BLA submission leadershipExecutive / board presentation developmentBusiness developmentAlliance managementCommercial strategy developmentBrand development, positioning, messaging, trade name Commercial launch planning - US/globalPricing StrategyForecasting & asset valuationsLife cycle managementCompetitive intelligence
-
Executive Director, Global Oncology Therapeutic Program LeadSpectrum Pharmaceuticals, Inc. Jan 2018 - Sep 2023Irvine, California, United StatesGlobal cross-functional program / operations lead for poziotinib (NSCLC) and eflapegrastim (long-acting G-CSF). Led multiple teams including Development, Preclinical, Regulatory, CMC, Quality, Medical Affairs, Commercial and Access/Reimbursement. Responsible for Driving day-to-day operations with a focus on execution excellence in support of BLA & NDA filings including timely issue identification and resolution. Asset’s primary point of contact with Executive Leadership◾️ Co-authored preliminary request for breakthrough designation. Based on this preliminary request the FDA requested a formal submission.◾️ Lead a multinational team to address time-critical issues in quality management, method validation,and process validation with a foreign CMO that had never undergone a PAI with the FDA. This resulted in a successful PAI with no program delays.◾️ Successfully spearheaded the poziotinib NDA submission, ensuring timely publication of modules and responses to all information requests.◾️ Drove selection of diagnostic partner following rigorous review process and co-led a successful sPMA/CDx submission for poziotinib.◾️ Successfully led eflapegrastim BLA resubmission, ensuring timely responses to all information requests ultimately leading to an FDA approval September 2022.◾️ Conceived and implemented monthly operations review meetings to track progress to corporate goals, highlighting key program issues and proposed mitigation strategies. -
Head Of Oncology Pipeline Strategy & CommercializationSpectrum Pharmaceuticals, Inc. Jan 2016 - Jan 2018Thousand Oaks, CaliforniaPipeline and inline therapeutic strategy lead for investigational assets including poziotinib, eflapegrastin and inline oncology brands including Evomela, Marqibo, Folotyn, and Beleodaq. Led pipeline strategy development, new product planning, TPP development and commercial assessments, forecasting, market research & competitive intelligence. In charge of leadership & coaching of commercial team, annual brand planning & execution.◾️ Successfully led cross-functional pipeline – asset strategy development initiatives, establishing clear and aligned cross-functional plans with gated resourcing.◾️ Communicated recommendations for pipeline assets leading to changes in poziotinib formulation development and initiation of on-body device development for eflapegrastim.◾️ Rebuilt marketing function and commercial operations; implemented annual brand planning processes and tracking process.◾️Adeptly managed commercial team exceeding sales goals for inline brands in ’17, ’18 by 12%, and 15% ◾️Recipient of 2017 Chairman’s Award for outstanding marketing leadership.
-
Senior Director Oncology Commercial LeadSpectrum Pharmaceuticals, Inc. Oct 2014 - Jan 2016Thousand Oaks, CaliforniaUS commercial launch lead for Evomela in multiple myeloma and US brand lead for Marqibo in ALL (acute lymphoblastic leukemia) Responsible for cross functional launch leadership, cross functional strategy development, Commercial team leadership, coaching and lifecycle planning.◾️ Launched Evomela in multiple myeloma, $160MM US market - core deliverables included brand name and trademark, positioning, promotional messaging, core sales tool development, branded website, pricing strategy, forecast and field force sizing.◾️ Initiated and co-led a prospective observational study that assessed administration time of IV melphalan to the stability of 60 minutes.◾️ Exceeded launch revenue goal for Evomela by 126% with an exit share of 37% after 9 months of sale. (56% YTD, Q2 2017).◾️ Recognized by CEO for outstanding Launch Team Leadership for Evomela – Rising Star Award 2016.◾️ Received outstanding Commercial Leadership Award for Evomela from Ligand Pharmaceuticals in 2017.
-
Director Product Strategy Team (Pst) Lead - Oncology TherapeuticsAmgen Apr 2006 - Oct 2014Thousand Oaks, CaliforniaLed 4 oncology therapeutic pipeline assets from Ph2 through Ph3 and commercial readiness. Global Product Strategy Team Lead responsible for maximizing asset value by enabling successful global development, filing and commercialization.◾️ Co-led multiple therapeutic oncology global product strategy teams to 4 separate global oncology therapeutic registration programs in SCCHN, NSCLC (2) and Gastric Cancer.◾️Successfully Led the Global Commercial Team (GCT), aligning on positioning, branding, messaging, and commercialization/launch strategy. ◾️ Established the rilotumumab and panitumumab global commercial teams (GCT); delivered T-18 global launch plan and forecast - coordinated and led launch readiness activities with archetype countries / markets.◾️ Championed a c-MET biomarker strategy resulting in meaningful competitive differentiation. ◾️Effectively managed strategic alliance with Japanese partner Astellas Pharma. ◾️ Amgen Global Oncology Commercial Lead of the Year Award – 2011.
John Fry Skills
Frequently Asked Questions about John Fry
What company does John Fry work for?
John Fry works for Pepromene Bio
What is John Fry's role at the current company?
John Fry's current role is Asset Strategy I Cross-Functional Leadership I Oncology Drug Development I Global Commercialization I Business Development I Alliance Management.
What is John Fry's email address?
John Fry's email address is jo****@****arm.com
What is John Fry's direct phone number?
John Fry's direct phone number is (805) 447*****
What skills is John Fry known for?
John Fry has skills like Oncology, Pharmaceutical Industry, Biotechnology, Commercialization, Life Sciences, Product Launch, Biopharmaceuticals, Marketing, Strategic Planning, Cross Functional Team Leadership, Pharmaceutical Sales, Management.
Not the John Fry you were looking for?
-
1hotmail.com
2 +160991XXXXX
-
3quanterix.com, analogic.com, beneschlaw.com
3 +197832XXXXX
-
4remedymed.com, mbres.com, yahoo.com, marcusmillichap.com
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial